Witamy! Darmowa dostawa od zamówień powyżej 130 € Dowiedz się więcej

Mounjaro 7.5mg

$ 231

Buy Mounjaro 7.5mg, a once-weekly tirzepatide injection for adults and children 10+ with type 2 diabetes. This dual GIP/GLP-1 receptor agonist provides advanced glycemic control, substantial A1C reductions, and impressive weight loss support when combined with diet and exercise. Convenient pre-filled pen for easy weekly dosing.

In Stock

-
+
Dodaj do życzenia
Dodaj do życzenia

Opis

Whats is Mounjaro 7.5m ?

Mounjaro 7.5mg (tirzepatide injection) is an FDA-approved prescription medication used as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years and older with type 2 diabetes mellitus. As a mid-range dose in the titration schedule, Mounjaro 7.5mg leverages the unique dual mechanism of a GIP and GLP-1 receptor agonist to deliver robust blood sugar regulation—stimulating insulin release when needed, suppressing glucagon, slowing gastric emptying, and reducing appetite for enhanced satiety and effective glucose management. Clinical evidence from the SURPASS trials demonstrates strong efficacy at the 7.5mg dose, with average A1C reductions of approximately 2.0-2.3% from baseline and body weight losses often exceeding 15-22 pounds or more (typically 10-15% of starting weight over 40-72 weeks), frequently surpassing results seen with other GLP-1 receptor agonists while also promoting cardiometabolic benefits like improved lipid profiles and blood pressure. The straightforward single-dose pre-filled pen delivers 7.5mg in 0.5mL via simple subcutaneous injection (abdomen, thigh, or upper arm) once weekly, generally reached after 4 weeks on 5mg (following the initial 2.5mg starting dose) to ensure smooth adjustment and minimize side effects such as nausea or gastrointestinal discomfort. While Mounjaro 7.5mg is not indicated specifically for weight loss (the same tirzepatide is available as Zepbound for chronic weight management), it offers exceptional dual benefits for patients with type 2 diabetes who benefit from superior glycemic control and significant weight reduction. Produced by Eli Lilly to rigorous pharmaceutical standards, Mounjaro 7.5mg provides consistent, sustained effects for long-term diabetes management and enhanced overall wellness. Always consult a healthcare provider before initiating Mounjaro 7.5mg to verify suitability, receive guidance on dose escalation, learn proper injection technique, and monitor for side effects (including common gastrointestinal issues that often improve with time) or interactions with other medications.